Ligand validation:4XTL

LFA: EICOSANE

LFA is a Ligand Of Interest in 4XTL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
4XTL_LFA_A_315	46%	89%	0.079	0.949	0.26	0.38	-	-	1	25%	0.25
4XTL_LFA_A_302	33%	85%	0.131	0.844	0.25	0.48	-	-	2	80%	0.8
4XTL_LFA_A_312	29%	81%	0.172	0.865	0.24	0.57	-	-	0	80%	0.8
4XTL_LFA_A_303	24%	87%	0.168	0.902	0.25	0.43	-	-	0	40%	0.2
4XTL_LFA_A_304	22%	83%	0.086	0.799	0.28	0.49	-	-	1	45%	0.45
4XTL_LFA_A_322	21%	90%	0.104	0.837	0.27	0.34	-	-	0	30%	0.3
4XTL_LFA_A_309	20%	85%	0.129	0.838	0.25	0.49	-	-	3	40%	0.4
4XTL_LFA_A_306	16%	90%	0.133	0.837	0.27	0.35	-	-	0	25%	0.25
4XTL_LFA_A_326	16%	83%	0.172	0.83	0.24	0.53	-	-	3	50%	0.5
4XTL_LFA_A_307	14%	83%	0.195	0.811	0.24	0.54	-	-	0	65%	0.65
4XTL_LFA_A_330	13%	85%	0.169	0.793	0.24	0.49	-	-	3	55%	0.55
4XTL_LFA_A_334	13%	83%	0.167	0.779	0.26	0.51	-	-	0	60%	0.6
4XTL_LFA_A_317	13%	81%	0.133	0.746	0.27	0.55	-	-	1	55%	0.55
4XTL_LFA_A_320	12%	89%	0.161	0.818	0.24	0.41	-	-	3	30%	0.3
4XTL_LFA_A_311	12%	86%	0.192	0.793	0.29	0.42	-	-	0	60%	0.6
4XTL_LFA_A_308	11%	86%	0.141	0.749	0.27	0.45	-	-	1	50%	0.5
4XTL_LFA_A_333	8%	87%	0.175	0.739	0.29	0.39	-	-	1	50%	0.5
4XTL_LFA_A_321	7%	89%	0.251	0.849	0.26	0.38	-	-	2	25%	0.25
4XTL_LFA_A_305	6%	91%	0.241	0.807	0.27	0.31	-	-	3	30%	0.3
4XTL_LFA_A_314	6%	82%	0.161	0.674	0.25	0.54	-	-	2	50%	0.5
4XTL_LFA_A_316	4%	88%	0.175	0.692	0.29	0.37	-	-	1	25%	0.25
4XTL_LFA_A_318	4%	84%	0.157	0.606	0.28	0.48	-	-	2	60%	0.6
4XTL_LFA_A_329	4%	86%	0.15	0.654	0.3	0.41	-	-	0	25%	0.25
4XTL_LFA_A_324	3%	90%	0.169	0.648	0.27	0.33	-	-	0	30%	0.3
4XTL_LFA_A_327	3%	87%	0.194	0.646	0.26	0.42	-	-	0	35%	0.35
4XTL_LFA_A_323	3%	75%	0.114	0.584	0.36	0.61	-	-	0	20%	0.2
4XTL_LFA_A_335	3%	88%	0.235	0.651	0.28	0.39	-	-	3	50%	0.5
4XTL_LFA_A_319	3%	85%	0.206	0.606	0.25	0.49	-	-	7	50%	0.5
4XTL_LFA_A_310	2%	88%	0.252	0.634	0.28	0.39	-	-	0	40%	0.4
4XTL_LFA_A_313	2%	88%	0.199	0.577	0.29	0.37	-	-	1	25%	0.25
4XTL_LFA_A_325	2%	89%	0.274	0.634	0.23	0.42	-	-	7	30%	0.3
4XTL_LFA_A_331	1%	74%	0.34	0.7	0.37	0.61	-	-	0	20%	0.2
4XTL_LFA_A_332	1%	87%	0.321	0.62	0.32	0.37	-	-	0	25%	0.25
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	70%	0.7
4XTN_LFA_J_311	43%	74%	0.092	0.958	0.38	0.61	-	-	1	20%	0.2
6XYT_LFA_C_309	41%	100%	0.165	0.878	0.07	0.05	-	-	0	100%	1
6RFC_LFA_A_336	39%	87%	0.105	0.92	0.24	0.46	-	-	0	40%	0.4
6YC3_LFA_C_313	39%	100%	0.159	0.866	0.07	0.04	-	-	1	100%	1
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	75%	0.75
8QLF_LFA_A_408	55%	100%	0.083	0.933	0.1	0.06	-	-	1	55%	0.55
4HYJ_LFA_B_302	48%	74%	0.164	0.962	0.2	0.79	-	-	1	70%	0.7
7Z09_LFA_A_801	40%	75%	0.087	0.914	0.37	0.58	-	-	1	35%	0.35

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

4XTL

LFA: EICOSANE

LFA is a Ligand Of Interest in 4XTL designated by the RCSB